• If you have questions about any of the listed studies, please contact BrainPark@monash.edu and request to be directed to the research team leading the study you're interested in.

    If you're a researcher and would like to have your study hosted at the BrainPark facility, please click here to find out how.

    ALFI-VR - Training the vulnerable teenage brain

    This study investigates the feasibility and preliminary efficacy of a new cognitive training program using virtual reality to improve inhibitory control in teenagers experiencing elevated levels of inattention, impulsivity or hyperactivity.


    Monash Autism and ADHD Genetics and Neurodevelopment (MAGNET) project

    The MAGNET project aims to better understand the complex symptoms of Autism Spectrum Disorders (ASD) and Attention Deficit Hyperactivity Disorder (ADHD), and why they overlap in some children. For more information about the MAGNET project, click here.


    Psychometric Validation and Normative Data for a Virtual Reality Test for Use in Sports Concussion

    Athletes with concussions may experience alterations in memory, attention, processing speed, reactive time, inhibitory control and decision-making. This study aims to determine the clinical utility of a newly developed computerised virtual reality neuropsychological test designed to detect cognitive deficits post-concussion.


    Support After Stroke with group-based classeS: The SASS study

    This study aims to test the potential effectiveness of a novel 12-week multicomponent group-based intervention for survivors of stroke living in the community to improve brain function and reduce the development of comorbidity and the risk of recurrent cardiovascular events using a randomised controlled trial design.


    Psilocybin-assisted psychotherapy in the treatment of Generalised Anxiety Disorder

    This is a Phase 2 randomised double-blind active-placebo-controlled trial to assess the safety and efficacy of psilocybin-assisted pharmacotherapy for Generalised Anxiety Disorder (GAD).


    MDMA-assisted psychotherapy for severe PTSD

    This is an open-label Phase 2 trial to assess the safety and efficacy of MDMA-assisted psychotherapy to treat severe post-traumatic stress disorder (PTSD).


    PsiConnect (psilocybin, connectivity and context) study

    This study examines brain connectivity changes following the administration of psilocybin using fMRI and EEG. The study also investigates how meditation training prior to psychedelic administration, and music and meditation during administration, influence participants' subjective responses and corresponding changes to brain connectivity.